The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer

Lin,Shuang‑Yan; Lv,Yan‑Bo; Mao,Gen‑Xiang; Chen,Xu‑Jiao; Peng,Fang

doi:10.3892/ol.2018.9477

The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer

Authors:
- Shuang‑Yan Lin
- Yan‑Bo Lv
- Gen‑Xiang Mao
- Xu‑Jiao Chen
- Fang Peng
View Affiliations

Affiliations: Department of Pathology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China, Department of Geriatrics, Zhejiang Provincial Key Lab of Geriatrics, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China, Department of Geriatrics, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China
Published online on: September 21, 2018 https://doi.org/10.3892/ol.2018.9477
Pages: 6721-6728

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Centromere protein U (CENPU) is a novel transcriptional repressor that is associated with different types of cancer. However, its function in breast cancer is poorly understood. In the present study, it was identified that CENPU was highly expressed in breast cancer tissues compared with expression in normal breast tissues (P=0.001). Furthermore, the CENPU mRNA level in tumors was often elevated, compared with the matched adjacent normal breast cancer tissue specimens in the dataset from The Cancer Genome Atlas database (n=106; P<0.001). To understand the function of CENPU in human breast carcinogenesis, its effects on the proliferation, apoptosis and cell cycle progression of MDA‑MB‑231 cells were examined using the lentiviral‑mediated CENPU knockdown approach. The RNA and protein expression levels in the transfected cells were monitored using reverse transcription‑quantitative polymerase chain reaction and western blotting, respectively. The mRNA and protein expression levels of the CENPU gene were significantly lower in the CENPU‑shRNA transfected cells than in the control (P<0.01), indicating successful gene expression knockdown. Post‑transfection, cell counting and MTT analysis revealed that the proliferation activity was significantly suppressed in CENPU knockdown cells relative to the control (P<0.01). Additionally, fluorescence activated cell sorting analysis revealed that the (G2+S) phase fraction was significantly declined in CENPU knockdown cells relative to the control; while the G1 phase fraction was significantly increased (P<0.01) and the percentage of the apoptotic cells was significantly increased (P<0.01). In conclusion, downregulation of CENPU gene expression may inhibit cell proliferation and cell cycle progression, and increase the apoptosis of the breast cancer cells. These results suggested a possible function of this protein in breast cancer pathogenesis and prognosis.

View Figures

View References

1	Yang WT and Zhu XZ: The introduction of 2012 WHO classification of tumours of the breast. Zhonghua Bing Li Xue Za Zhi. 42:78–80. 2013.(In Chinese). PubMed/NCBI
2	Kreiter E, Richardson A, Potter J and Yasui Y: Breast cancer: Trends in international incidence in men and women. Br J Cancer. 110:1891–1897. 2014. View Article : Google Scholar : PubMed/NCBI
3	Makki J, Myint O, Wynn AA, Samsudin AT and John DV: Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics. Clin Med Insights Pathol. 8:1–16. 2015. View Article : Google Scholar : PubMed/NCBI
4	Makki J: Diversity of breast carcinoma: Histological subtypes and clinical relevance. Clin Med Insights Pathol. 8:23–31. 2015. View Article : Google Scholar : PubMed/NCBI
5	Morris LG and Chan TA: Therapeutic targeting of tumor suppressor genes. Cancer. 121:1357–1368. 2015. View Article : Google Scholar : PubMed/NCBI
6	Lee YT, Tan YJ and Oon CE: Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 834:188–196. 2018. View Article : Google Scholar : PubMed/NCBI
7	Bode AM, Dong Z and Wang H: Cancer prevention and control: Alarming challenges in China. Natl Sci Rev. 3:117–127. 2016. View Article : Google Scholar : PubMed/NCBI
8	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
9	Pan HY, Zhang YJ, Wang XP, Deng JH, Zhou FC and Gao SJ: Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol. 77:9758–9768. 2003. View Article : Google Scholar : PubMed/NCBI
10	Zhang L, Ji G, Shao Y, Qiao S, Jing Y, Qin R, Sun H and Shao C: MLF1 interacting protein: A potential gene therapy target for human prostate cancer? Med Oncol. 32:4542015.PubMed/NCBI
11	Hanissian SH, Teng B, Akbar U, Janjetovic Z, Zhou Q, Duntsch C and Robertson JH: Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma. Brain Res. 1047:56–64. 2005. View Article : Google Scholar : PubMed/NCBI
12	Huang DP and Luo RC: MLF1IP is correlated with progression and prognosis in luminal breast cancer. Biochem Biophys Res Commun. 477:923–926. 2016. View Article : Google Scholar : PubMed/NCBI
13	Hanissian SH, Akbar U, Teng B, Janjetovic Z, Hoffmann A, Hitzler JK, Iscove N, Hamre K, Du X, Tong Y, et al: cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP. Oncogene. 23:3700–3707. 2004. View Article : Google Scholar : PubMed/NCBI
14	Grbesa I, Pajares MJ, Martinez-Terroba E, Agorreta J, Mikecin AM, Larráyoz M, Idoate MA, Gall-Troselj K, Pio R and Montuenga LM: Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients. PLoS One. 10:e01246702015. View Article : Google Scholar : PubMed/NCBI
15	Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, et al: Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI
16	You TK, Kim KM, Noh SJ, Bae JS, Jang KY, Chung MJ, Moon WS, Kang MJ, Lee DG and Park HS: Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous hyperplasia and squamous cell carcinoma of the head and neck: Their relationships with clinicopathologic factors and prognostic implication. Korean J Pathol. 46:331–340. 2012. View Article : Google Scholar : PubMed/NCBI
17	Chandran UR, Medvedeva OP, Barmada MM, Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z, et al: TCGA expedition: A data acquisition and management system for TCGA data. PLoS One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
20	Burnette WN: ‘Western blotting’: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 112:195–203. 1981. View Article : Google Scholar : PubMed/NCBI
21	Fuentes JM, Lompré AM, Møller JV, Falson P and le Maire M: Clean Western blots of membrane proteins after yeast heterologous expression following a shortened version of the method of Perini et al. Anal Biochem. 285:276–278. 2000. View Article : Google Scholar : PubMed/NCBI
22	Robinson MD, McCarthy DJ and Smyth GK: edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26:139–140. 2010. View Article : Google Scholar : PubMed/NCBI
23	Minoshima Y, Hori T, Okada M, Kimura H, Haraguchi T, Hiraoka Y, Bao YC, Kawashima T, Kitamura T and Fukagawa T: The constitutive centromere component CENP-50 is required for recovery from spindle damage. Mol Cell Biol. 25:10315–10328. 2005. View Article : Google Scholar : PubMed/NCBI
24	Lee KS, Oh DY, Kang YH and Park JE: Self-regulated mechanism of Plk1 localization to kinetochores: Lessons from the Plk1-PBIP1 interaction. Cell Div. 3:42008. View Article : Google Scholar : PubMed/NCBI
25	Hua S, Wang Z, Jiang K, Huang Y, Ward T, Zhao L, Dou Z and Yao X: CENP-U cooperates with Hec1 to orchestrate kinetochore-microtubule attachment. J Biol Chem. 286:1627–1638. 2011. View Article : Google Scholar : PubMed/NCBI
26	Hori T, Okada M, Maenaka K and Fukagawa T: CENP-O class proteins form a stable complex and are required for proper kinetochore function. Mol Biol Cell. 19:843–854. 2008. View Article : Google Scholar : PubMed/NCBI
27	Chou HL, Yao CT, Su SL, Lee CY, Hu KY, Terng HJ, Shih YW, Chang YT, Lu YF, Chang CW, et al: Gene expression profiling of breast cancer survivability by pooled cDNA microarray analysis using logistic regression, artificial neural networks and decision trees. BMC Bioinformatics. 14:1002013. View Article : Google Scholar : PubMed/NCBI